End-of-day quote
Shanghai S.E.
23:00:00 16/05/2024 BST
|
5-day change
|
1st Jan Change
|
10.06
CNY
|
+1.31%
|
|
-0.20%
|
+18.08%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,870
|
5,360
|
5,483
|
7,389
|
7,780
|
6,663
|
Enterprise Value (EV)
1 |
4,372
|
5,963
|
5,663
|
7,586
|
7,130
|
5,339
|
P/E ratio
|
19.7
x
|
20.5
x
|
37
x
|
22.1
x
|
9.62
x
|
8.93
x
|
Yield
|
1.17%
|
1.48%
|
0.82%
|
1.57%
|
3.61%
|
4.99%
|
Capitalization / Revenue
|
1.04
x
|
1.28
x
|
1.39
x
|
1.55
x
|
1.3
x
|
1.17
x
|
EV / Revenue
|
1.58
x
|
1.42
x
|
1.44
x
|
1.59
x
|
1.19
x
|
0.94
x
|
EV / EBITDA
|
7.6
x
|
9.02
x
|
10.8
x
|
9.34
x
|
4.92
x
|
4.32
x
|
EV / FCF
|
-33.2
x
|
32.8
x
|
11.8
x
|
-1,566
x
|
7.62
x
|
5.2
x
|
FCF Yield
|
-3.01%
|
3.05%
|
8.47%
|
-0.06%
|
13.1%
|
19.2%
|
Price to Book
|
1.29
x
|
1.35
x
|
1.36
x
|
1.7
x
|
1.54
x
|
1.2
x
|
Nbr of stocks (in thousands)
|
559,440
|
775,731
|
774,380
|
772,927
|
780,341
|
782,089
|
Reference price
2 |
5.130
|
6.910
|
7.080
|
9.560
|
9.970
|
8.520
|
Announcement Date
|
15/04/19
|
27/04/20
|
28/04/21
|
27/04/22
|
17/04/23
|
29/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,764
|
4,190
|
3,937
|
4,761
|
5,969
|
5,682
|
EBITDA
1 |
575.4
|
660.9
|
526.3
|
812.2
|
1,449
|
1,237
|
EBIT
1 |
262.3
|
282.5
|
145.8
|
430.1
|
1,023
|
817.1
|
Operating Margin
|
9.49%
|
6.74%
|
3.7%
|
9.03%
|
17.14%
|
14.38%
|
Earnings before Tax (EBT)
1 |
182.2
|
322.6
|
191.8
|
415.8
|
1,019
|
912.6
|
Net income
1 |
144.9
|
261.3
|
148.4
|
334.3
|
803.9
|
738.4
|
Net margin
|
5.24%
|
6.23%
|
3.77%
|
7.02%
|
13.47%
|
12.99%
|
EPS
2 |
0.2600
|
0.3368
|
0.1916
|
0.4317
|
1.037
|
0.9536
|
Free Cash Flow
1 |
-131.6
|
181.7
|
479.4
|
-4.845
|
935.4
|
1,028
|
FCF margin
|
-4.76%
|
4.34%
|
12.18%
|
-0.1%
|
15.67%
|
18.08%
|
FCF Conversion (EBITDA)
|
-
|
27.49%
|
91.08%
|
-
|
64.56%
|
83.08%
|
FCF Conversion (Net income)
|
-
|
69.55%
|
323.13%
|
-
|
116.35%
|
139.16%
|
Dividend per Share
2 |
0.0600
|
0.1020
|
0.0580
|
0.1500
|
0.3600
|
0.4250
|
Announcement Date
|
15/04/19
|
27/04/20
|
28/04/21
|
27/04/22
|
17/04/23
|
29/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,502
|
603
|
180
|
197
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
650
|
1,325
|
Leverage (Debt/EBITDA)
|
2.61
x
|
0.9117
x
|
0.3418
x
|
0.2425
x
|
-
|
-
|
Free Cash Flow
1 |
-132
|
182
|
479
|
-4.84
|
935
|
1,028
|
ROE (net income / shareholders' equity)
|
6.7%
|
6.55%
|
3.67%
|
7.87%
|
16.7%
|
13.1%
|
ROA (Net income/ Total Assets)
|
3.56%
|
2.55%
|
1.27%
|
3.5%
|
7.19%
|
5.15%
|
Assets
1 |
4,070
|
10,257
|
11,668
|
9,543
|
11,189
|
14,335
|
Book Value Per Share
2 |
3.970
|
5.110
|
5.220
|
5.610
|
6.460
|
7.090
|
Cash Flow per Share
2 |
0.7100
|
1.360
|
1.580
|
1.330
|
2.920
|
3.960
|
Capex
1 |
476
|
349
|
382
|
498
|
368
|
383
|
Capex / Sales
|
17.22%
|
8.32%
|
9.7%
|
10.45%
|
6.17%
|
6.74%
|
Announcement Date
|
15/04/19
|
27/04/20
|
28/04/21
|
27/04/22
|
17/04/23
|
29/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +18.08% | 1.08B | | +5.41% | 105B | | -3.11% | 64.71B | | +73.33% | 49.72B | | +17.24% | 38.6B | | +6.13% | 32.54B | | +12.77% | 19.94B | | +15.03% | 16.92B | | +19.06% | 15.2B | | +6.28% | 14.39B |
Other Commodity Chemicals
|